Brief

On 04/08/2025, the Therapeutic Goods Administration (TGA) issued an update regarding Efficacy of Vitamin D for bone strength. The TGA initiated targeted compliance reviews of listed medicines containing Vitamin D and found insufficient evidence to support bone strength claims made by sponsors, leading to removal of claims, cancellation of four medicines, and issuance of one infringement notice.

This content is restricted.

Highlights content goes here...

This content is restricted.

Therapeutic Goods Administration (TGA)

Quick Insight
RADA.AI
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Enter your registered username/email id.

Enter your Email

Enter your email id below to signup.
Individual Plan
$125 / month OR $1250 / year
Features
Best for: Researchers, Legal professionals, Academics
Enterprise Plan
Contact for Pricing
Features
Best for: Law Firms, Corporations, Government Bodies